Surgery Partners Inc. (SGRY)
NASDAQ:SGRY
Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.00
$0.26(1.26%)
At close: 4:00 PM EST
$14.00
$0.26(1.26%)
Day’s Range― - ―
52-Week Range$11.41 - $24.10
Previous CloseN/A
Volume149.01K
Average Volume (3M)1.40M
Market Cap
$2.07B
Enterprise Value$5.71B
Total Cash (Recent Filing)$182.30M
Total Debt (Recent Filing)$4.03B
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Aug 04, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding130,788,160
10 Day Avg. Volume1,160,325
30 Day Avg. Volume1,401,138
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap2.76
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit7.87
Enterprise Value/Ebitda5.96
Forecast
1Y Price Target
$17.10Price Target Upside22.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.43
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationStable, consistently positive operating and free cash flow provides durable internal funding for maintenance capex, physician distributions, and debt service. This underpins the company's ability to reinvest in de novos and robotics, and supports gradual deleveraging even with elevated nominal debt levels.
Steady Top‑Line GrowthConsistent mid-single-digit revenue growth reflects recurring demand for outpatient procedures and expansion of higher‑acuity services. Sustained revenue momentum supports margin leverage and helps absorb cost pressures from provider taxes and reimbursement shifts over a multi‑quarter horizon.
Physician Recruitment & Robotics MomentumActive physician recruiting, de novo facility growth and investment in robotics strengthen referral pipelines and enable higher‑acuity case mix (MSK/joints). These structural trends increase revenue per case and create competitive differentiation at facility level over the coming quarters.
Bears Say
Elevated LeverageHigh and rising leverage materially reduces financial flexibility, increases interest expense sensitivity, and constrains strategic optionality. If procedure volumes or reimbursement deteriorate, servicing sizable debt could force slower M&A, asset sales, or curtailed reinvestment, raising execution risk.
Persistent Net LossesOngoing GAAP losses, despite positive EBITDA, indicate structural pressure on the bottom line from non‑cash or one‑time items and interest costs. Persistent negative earnings limit retained earnings accumulation and can hinder credit metrics improvement even if operational cash flow stays positive.
Below‑Trend Case GrowthWeak same‑facility case growth signals vulnerability in demand or scheduling that can cap revenue per site and delay margin recovery. If cases remain below historical trends, returns on new de novos and robotics investments may take longer to realize, pressuring medium‑term profitability.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc.’s price range in the past 12 months?
Surgery Partners Inc. lowest stock price was $11.41 and its highest was $24.10 in the past 12 months.
What is Surgery Partners Inc.’s market cap?
Surgery Partners Inc.’s market cap is $2.07B.
When is Surgery Partners Inc.’s upcoming earnings report date?
Surgery Partners Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 38 days.
How were Surgery Partners Inc.’s earnings last quarter?
Surgery Partners Inc. released its earnings results on May 05, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.124 by $0.094.
Is Surgery Partners Inc. overvalued?
According to Wall Street analysts Surgery Partners Inc.’s price is currently Undervalued.
Does Surgery Partners Inc. pay dividends?
Surgery Partners Inc. does not currently pay dividends.
What is Surgery Partners Inc.’s EPS estimate?
Surgery Partners Inc.’s EPS estimate is 0.06.
How many shares outstanding does Surgery Partners Inc. have?
Surgery Partners Inc. has 130,788,160 shares outstanding.
What happened to Surgery Partners Inc.’s price movement after its last earnings report?
Surgery Partners Inc. reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.124. Following the earnings report the stock price went up 0.423%.
Which hedge fund is a major shareholder of Surgery Partners Inc.?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.10 (22.14% Upside)
$17.10 (22.14% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.78%
12-Months-Change
Fundamentals
Return on Equity
-4.43%
Trailing 12-Months
Asset Growth
1.17%
Trailing 12-Months
Company Description
Surgery Partners Inc.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Neutral — The call conveyed cautious optimism: the company reported solid revenue and EBITDA in line with expectations, strong MSK/robotics momentum, physician recruiting progress and reiterated full‑year guidance, but those positives are counterbalanced by below‑trend case growth, payer mix/provider tax headwinds, rising interest expense and elevated leverage that temper near‑term upside.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$17.10
▲(22.14% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
39.86% Insiders
26.13% Mutual Funds
4.01% Other Institutional Investors
19.41% Public Companies and
Individual Investors